Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab

被引：31
|
作者：
Helbling, D. [1 ]
Borner, M. [1 ]
机构：
[1] Univ Bern, Inselspital Bern, Clin Med Oncol, Dept Med Oncol, CH-3010 Bern, Switzerland
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷 / 05期
关键词：
D O I：
10.1093/annonc/mdm130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：963 / 964
页数：2
相关论文
共 50 条
  • [1] Infusion reactions to the chimeric EGFR inhibitor cetuximab-change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
    Resch, G.
    Schaberl-Moser, R.
    Kier, P.
    Kopetzky, G.
    Scheithauer, W.
    Sliwa, T.
    Greil, R.
    Noesslinger, T.
    Mayrbaeurl, B.
    Thaler, J.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 486 - U251
  • [2] Successful treatment with the fully human antibody panitumumab after a severe infusion reaction with cetuximab
    Brugger, Wolfram
    TUMORI, 2010, 96 (03) : 473 - 477
  • [3] Differentiation between the EGFR antibodies necitumumab, cetuximab, and panitumumab: Antibody internalization and EGFR degradation
    Topper, M. B.
    Tonra, J. R.
    Pytowski, B.
    Eastman, S. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR
    Liu, San-Hu
    Chen, Xue-Fang
    Zhi-Bin Xie
    Zhou, Jie
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (01) : 79 - 88
  • [5] Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer
    Peeters, M.
    Balfour, J.
    Arnold, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 269 - 281
  • [6] Panitumumab.: Oncolytic -: Anti-EGFR human monoclonal antibody.
    McIntyre, JA
    Martín, L
    DRUGS OF THE FUTURE, 2004, 29 (08) : 793 - 797
  • [7] Anti EGFR antibody (Cetuximab) in metastatic colorectal cancer
    Krause, M
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (11) : 742 - 743
  • [8] Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
    Brand, Toni M.
    Iida, Mari
    Wheeler, Deric L.
    CANCER BIOLOGY & THERAPY, 2011, 11 (09) : 777 - 792
  • [9] Cetuximab. Anti-EGFR monoclonal antibody
    Etessami, A
    Bourhis, J
    DRUGS OF THE FUTURE, 2000, 25 (09) : 895 - 899
  • [10] Epitope mapping and eludication of the mechanism of action of panitumumab, a fully human monoclonal antibody targeting the epidermal growth factor receptor (EGFR)
    Freeman, Dan
    Sun, Jilin
    Bass, Randall
    Chong, Ken
    Ogbagabriel, Selam
    Elliott, Gary
    Radinsky, Robert
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3472S - 3472S
12345